Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Process For The Preparation Of HMG-COA reductase inhibitors and intermediates thereof

一种C1-C6、-CH2SO2R5的技术,应用在制备HMG-CoA还原酶抑制剂领域,能够解决不适于大规模工业化生产等问题

Active Publication Date: 2013-04-03
YUHAN
View PDF11 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, in order to prepare intermediates containing lactone rings, multiple steps are required, including cyclization under stringent conditions, making this method unsuitable for large-scale industrial production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Process For The Preparation Of HMG-COA reductase inhibitors and intermediates thereof
  • Process For The Preparation Of HMG-COA reductase inhibitors and intermediates thereof
  • Process For The Preparation Of HMG-COA reductase inhibitors and intermediates thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0078] In the preparation method (i.e. deprotection method) of the compound of formula 6, the acid can be selected from hydrochloric acid, sulfuric acid, phosphoric acid, nitric acid, acetic acid, formic acid, sulfonic acid and mixtures thereof; preferably an inorganic acid such as hydrochloric acid, sulfuric acid, phosphoric acid or nitric acid; more preferably hydrochloric acid. The amount of acid used may be a catalytic amount. Typically, the acid is used in an amount of 0.005-0.2 equivalents relative to 1 equivalent of the compound of formula 4, but it is not limited thereto. And, the reaction can be carried out at 20-80°C, preferably 30-50°C, more preferably about 40°C. Therefore, since the method of the present invention can be implemented under mild conditions, it is very suitable for large-scale industrial production. The reaction can be carried out in the presence of a solvent selected from water, C 1 -C 10 Alcohols (such as methanol, ethanol, isopropanol, butanol...

Embodiment 1

[0161] 2-[(4R,6S)-6-Hydroxymethyl-2,2-dimethyl-[1,3]dioxan-4-yl]-N-methoxy-N-methyl-acetamide

[0162] [(4R,6S)-6-Hydroxymethyl-2,2-dimethyl-[1,3]dioxan-4-yl]-acetic acid (50.0 g), acetonitrile (500.0 mL) and chloride Ammonium (1.3 g) was charged to the reactor. The reaction mixture was cooled to 0-5°C, then hexamethyldisilazane (102.1 mL) was slowly added thereto. The reaction mixture was stirred at 30 °C for 1 h, then concentrated under reduced pressure to remove the solvent. Ethyl acetate (250.0 mL) and water (200.0 mL) were added to the obtained residue. The separated organic layer was dehydrated with anhydrous magnesium sulfate (50.0 g), and then filtered under reduced pressure. The filtrate was concentrated under reduced pressure to obtain a colorless transparent oily concentrated residue. Dichloromethane (250.0 mL) was added to the concentrated residue. The reaction mixture was cooled to 0-5°C, and then 1,1'-carbonyldiimidazole (43.7 g) was slowly added thereto. T...

Embodiment 2

[0165] 2-[(4R,6S)-6-Formyl-2,2-dimethyl-[1,3]dioxan-4-yl]-N-methoxy-N-methyl-acetamide

[0166] Under nitrogen atmosphere, 2-[(4R,6S)-6-hydroxymethyl-2,2-dimethyl-[1,3]dioxan-4-yl]-N-methoxy-N - Methyl-acetamide (5.0 g), dichloromethane (30.0 mL) and Dess-Martin oxidant (11.2 g) were charged to the reactor. The reaction mixture was stirred at 20-30 °C for more than 5 h. Water (30.0 mL) was added to the reaction mixture. The separated organic layer was concentrated under reduced pressure. The obtained residue was purified using silica gel column chromatography (ethyl acetate / n-hexane=1:3) to obtain 2-[(4R,6S)-6-formyl-2,2-dimethyl-[1, 3] Dioxan-4-yl]-N-methoxy-N-methyl-acetamide (4.3 g, 87% yield).

[0167] 1 H-NMR, 400MHz, CDCl 3 ,ppm:1.30(m,1H),1.46(s,3H),1.51(s,3H),1.92(d,1H),2.42~2.83(dd,2H),3.19(s,3H),3.69(s ,3H), 4.37(d,1H), 4.48(m,1H), 9.58(s,1H).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides an improved process for preparing HMG-CoA reductase inhibitors such as rosuvastatin calcium, fluvastatin sodium, and pitavastatin calcium under a mild condition, using a novel amide-bond-containing compound having R2-N-O-R1 moiety as a key intermediate. And also, the present invention provides the novel compound, an intermediate useful for the preparation thereof, and a process for the preparation thereof.

Description

technical field [0001] The present invention relates to a process for the preparation of HMG-CoA reductase inhibitors using novel intermediates. The invention also relates to novel intermediates and processes for their preparation. Background technique [0002] HMG-CoA reductase inhibitors such as rosuvastatin calcium, fluvastatin sodium, pitavastatin calcium are known as drugs for lowering LDL-cholesterol and triglyceride levels (for example, EP0521471, US5354772, EP0304063, etc.). The chemical name of rosuvastatin calcium is E-7-[2-(N-methyl-N-methylsulfonylamino)-4-(4-fluorophenyl)-6-isopropyl-pyrimidine-5- base]-(3R,5S)-3,5-dihydroxyhept-6-enoic acid 1 / 2 calcium salt. The chemical name of fluvastatin sodium is (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-di Hydroxyhept-6-enoic acid sodium salt. The chemical name of pitavastatin calcium is (3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyheptyl- 6-enoic acid 1 / 2 calcium sal...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D405/06C07D239/18A61K31/443
CPCC07D405/06C07D215/14C07D209/18C07D239/42C07D405/12A61K31/443C07D239/69C07D209/24A61P43/00Y02P20/55C07D209/08A61K31/505
Inventor 朱贤郑相宣李炫稷具滋奕林钟喆金在圭
Owner YUHAN
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products